MDL 2809 — Onglyza (Saxagliptin) and Kombiglyze XR (Saxagliptin and Metformin) Products Liability Litigation

Off the roster — last appeared 2022-07-15, which usually means the litigation resolved, settled, or closed.

Pending actions over time

Civil actions pending in this MDL, from JPML's monthly Actions-Pending reports.

Roster timeline

Each cell is one monthly JPML report (2014-02-19 → 2026-08-03); filled cells are months this MDL was on the pending roster.

Related Consumer Products

• MDL 3060 — Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation — 11,779 pending
• MDL 2974 — Paragard IUD Products Liability Litigation — 4,156 pending
• MDL 3047 — Social Media Adolescent Addiction/Personal Injury Products Liability Litigation — 3,137 pending
• MDL 3044 — Exactech Polyethylene Orthopedic Products Liability Litigation — 1,838 pending
• MDL 3092 — Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation — 1,827 pending
• MDL 2848 — Zostavax (Zoster Vaccine Live) Products Liability Litigation — 826 pending

All consumer products MDLs →

Sources

• JPML Pending MDLs (official)
• Roster report containing this row

Roster presence is our derivation from JPML's monthly PDFs; confirm current status with the court before relying on it.